Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Future Medicinal Chemistry|May 13, 2017
Chalcone-based carbamates for Alzheimer's disease treatmentAngela Rampa, Serena Montanari, Letizia Pruccoli, et al.Molecules (Basel, Switzerland)|June 2, 2021
New Coumarin Derivatives as Cholinergic and Cannabinoid System ModulatorsSerena Montanari, Marco Allarà, Laura Scalvini, et al.Journal of Medicinal Chemistry|June 17, 2016
Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease AgentsSerena Montanari, Laura Scalvini, Manuela Bartolini, et al.European Journal of Medicinal Chemistry|April 1, 2014
Fluorinated benzophenone derivatives: balanced multipotent agents for Alzheimer's diseaseFederica Belluti, Angela De Simone, Andrea Tarozzi, et al.Chemmedchem|October 29, 2015
Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based DerivativesSerena Montanari, Manuela Bartolini, Paolo Neviani, et al.European Journal of Medicinal Chemistry|August 16, 2017
Hydroxy-substituted trans-cinnamoyl derivatives as multifunctional tools in the context of Alzheimer's diseaseAngela De Simone, Manuela Bartolini, Andrea Baschieri, et al.European Journal of Medicinal Chemistry|July 27, 2020
Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12-dione as an antiproliferative agent and to treat cancerElena Catanzaro, Nibal Betari, Jose M Arencibia, et al.European Journal of Medicinal Chemistry|June 12, 2019
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatmentSerena Montanari, Ali Mokhtar Mahmoud, Letizia Pruccoli, et al.ACS Chemical Neuroscience|May 15, 2024
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer's DiseaseAlan Santini, Elisa Tassinari, Eleonora Poeta, et al.ACS Medicinal Chemistry Letters|September 19, 2019
Correction to "Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease"Angela De Simone, Valeria La Pietra, Nibal Betari, et al.Pageof 3